Orion finds replacement for its retiring Senior Vice President for Research and Development in Eli Lilly
February 13, 2017Orion Group’s Senior Vice President for Research and Development and member of the Executive Management Board Dr. Reijo Salonen, will step down on February 21, 2017.
Dr. Salonen has been appointed to the position of Senior Advisor until July 1, 2017 when he will retire.
Replacement for Dr. Salonen will be Dr.Christer Nordstedt, M.D., Ph.D. who will join the company from Eli Lilly where he was appointed as Vice President and Head CNS Research and Clinical Investigation.
